Angiotensin receptor-neprilysin inhibiton (ARNI) - A novel therapeutic concept for management of hypertension and heart failure

被引：8
|
作者：
Kjeldsen, Sverre E. [1 ]
Hedner, Thomas [2 ]
Narkiewicz, Krzysztof [3 ]
Oparil, Suzanne [4 ]
机构：
[1] Univ Oslo, Ullevaal Hosp, Dept Cardiol, N-0407 Oslo, Norway
[2] Univ Gothenburg, Sahlgrenska Acad, Dept Med, Gothenburg, Sweden
[3] Med Univ Gdansk, Dept Hypertens & Diabetol, Gdansk, Poland
[4] Univ Alabama Birmingham, Vasc Biol & Hypertens Program, Birmingham, AL USA
来源：
BLOOD PRESSURE | 2012年 / 21卷 / 06期
关键词：
NATRIURETIC-PEPTIDE; SYSTEM; BIOLOGY; TARGET; LCZ696;
D O I：
10.3109/10582452.2012.741765
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：329 / 330
页数：2
相关论文
共 50 条
  • [1] Is it time to adopt angiotensin receptor-neprilysin inhibitors (ARNI) therapy as standard of care for the management of hypertension?
    Ali, Ayan
    Ortega-Legaspi, Juan M.
    ANNALS OF PALLIATIVE MEDICINE, 2022,
  • [2] Angiotensin Receptor-Neprilysin Inhibitor (ARNI) and Cardiac Arrhythmias
    Sutanto, Henry
    Dobrev, Dobromir
    Heijman, Jordi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
  • [3] Angiotensin Receptor-Neprilysin Inhibition (ARNI) Therapy and Reverse Remodeling in Heart Failure With Reduced Ejection Fraction
    Drazner, Mark H.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (11): : 1051 - 1053
  • [4] Role of Angiotensin Receptor-Neprilysin Inhibition in Heart Failure
    Prenner, Stuart B.
    Shah, Sanjiv J.
    Yancy, Clyde W.
    CURRENT ATHEROSCLEROSIS REPORTS, 2016, 18 (08)
  • [5] Role of Angiotensin Receptor-Neprilysin Inhibition in Heart Failure
    Stuart B. Prenner
    Sanjiv J. Shah
    Clyde W. Yancy
    Current Atherosclerosis Reports, 2016, 18
  • [6] Angiotensin Receptor-Neprilysin Inhibition: New Therapeutic Concept for the Management of Chronic Heart Failure: Development, Clinical Implications, and Future Perspectives
    Havakuk, Ofer
    Elkayam, Uri
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2017, 22 (04) : 356 - 364
  • [7] Practical Recommendations for the Use of Angiotensin Receptor-Neprilysin Inhibitors (ARNI) in Heart Failure: Insights from Indian Cardiologists
    Jamshed Dalal
    Praveen Chandra
    Saumitra Ray
    P. K. Hazra
    Jagdish Hiremath
    Viveka Kumar
    Mahesh K. Shah
    Jabir Abdullakutty
    Debasis Ghosh
    Karthik Vasudevan
    Panchanan Sahoo
    Cardiology and Therapy, 2023, 12 : 445 - 471
  • [8] Practical Recommendations for the Use of Angiotensin Receptor-Neprilysin Inhibitors (ARNI) in Heart Failure: Insights from Indian Cardiologists
    Dalal, Jamshed
    Chandra, Praveen
    Ray, Saumitra
    Hazra, P. K.
    Hiremath, Jagdish
    Kumar, Viveka
    Shah, Mahesh K. K.
    Abdullakutty, Jabir
    Ghosh, Debasis
    Vasudevan, Karthik
    Sahoo, Panchanan
    CARDIOLOGY AND THERAPY, 2023, 12 (03) : 445 - 471
  • [9] Impact of angiotensin receptor-neprilysin inhibition (ARNI) in improving ejection fraction and left and right ventricular remodeling in heart failure
    Bhushan, Sandeep
    Huang, Xin
    Jiang, Fenglin
    Xiao, Zongwei
    CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (04)
  • [10] Getting the "Right" Perspective on Angiotensin Receptor-Neprilysin Inhibition in Heart Failure
    Verbrugge, Frederik H.
    Borlaug, Barry A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (13):
12345